Discovery of a novel and potent, and urea isostere inhibitors series of dianilinopyrimidineurea of VEGFR2 tyrosine kinase

被引:33
|
作者
Sammond, DM [1 ]
Nallor, KE [1 ]
Veal, JM [1 ]
Nolte, RT [1 ]
Wang, LP [1 ]
Knick, VB [1 ]
Rudolph, SK [1 ]
Truesdale, AT [1 ]
Nartey, EN [1 ]
Stafford, JA [1 ]
Kumar, R [1 ]
Cheung, M [1 ]
机构
[1] GlaxoSmithKline, Res Triangle Pk, NC 27709 USA
关键词
VEGFR2; FLK-1; KDR; kinase inhibitor;
D O I
10.1016/j.bmcl.2005.05.096
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of dianilinopyrimidineureas demonstrate potency as VEGFR2 kinase inhibitors. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3519 / 3523
页数:5
相关论文
共 50 条
  • [21] Discovery of novel dual VEGFR2 and Src inhibitors using a multistep virtual screening approach
    Chen, Shangying
    Qin, Chu
    Sin, Jia En
    Yang, Xuan
    Tao, Lin
    Zeng, Xian
    Zhang, Peng
    Gao, Chun Mei
    Jiang, Yu Yang
    Zhang, Cheng
    Chen, Yu Zong
    Chui, Wai Keung
    FUTURE MEDICINAL CHEMISTRY, 2017, 9 (01) : 7 - 24
  • [22] Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour models
    Dev, IK
    Dornsife, RE
    Hopper, TM
    Onori, JA
    Miller, CG
    Harrington, LE
    Dold, KM
    Mullin, RJ
    Johnson, JH
    Crosby, RM
    Truesdale, AT
    Epperly, AH
    Hinkle, KW
    Cheung, M
    Stafford, JA
    Luttrell, DK
    Kumar, R
    BRITISH JOURNAL OF CANCER, 2004, 91 (07) : 1391 - 1398
  • [23] Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour models
    I K Dev
    R E Dornsife
    T M Hopper
    J A Onori
    C G Miller
    L E Harrington
    K M Dold
    R J Mullin
    J H Johnson
    R M Crosby
    A T Truesdale
    A H Epperly
    K W Hinkle
    M Cheung
    J A Stafford
    D K Luttrell
    R Kumar
    British Journal of Cancer, 2004, 91 : 1391 - 1398
  • [24] Synthesis, Anticancer Screening of Some Novel Trimethoxy Quinazolines and VEGFR2, EGFR Tyrosine Kinase Inhibitors Assay; Molecular Docking Studies
    Altamimi, Abdulmalik S.
    El-Azab, Adel S.
    Abdelhamid, Sami G.
    Alamri, Mubarak A.
    Bayoumi, Ashraf H.
    Alqahtani, Safar M.
    Alabbas, Alhumaidi B.
    Altharawi, Ali, I
    Alossaimi, Manal A.
    Mohamed, Menshawy A.
    MOLECULES, 2021, 26 (10):
  • [25] Novel thioureido-benzenesulfonamide derivatives with enaminone linker as potent anticancer, radiosensitizers and VEGFR2 inhibitors
    Ghorab, Mostafa M.
    Ragab, Fatma A.
    Heiba, Helmy, I
    El-Gazzar, Marwa G.
    El-Gazzar, Mostafa G. M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (09) : 1464 - 1470
  • [26] Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyrosine kinase (SYK)
    Farmer, Luc J.
    Bemis, Guy
    Britt, Shawn D.
    Cochran, John
    Connors, Martin
    Harrington, Edmund M.
    Hoock, Thomas
    Markland, William
    Nanthakumar, Suganthini
    Taslimi, Paul
    Ter Haar, Ernst
    Wang, Jian
    Zhaveri, Darshana
    Salituro, Francesco G.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (23) : 6231 - 6235
  • [27] Structure activity relationships of chrysoeriol and analogs as dual c-Met and VEGFR2 tyrosine kinase inhibitors
    Lai, Shuang
    Chen, Jun-Ning
    Huang, Han-Wei
    Zhang, Xiang-Yu
    Jiang, Hai-Lun
    Li, Wei
    Wang, Peng-Liang
    Wang, Jian
    Liu, Fu-Nan
    ONCOLOGY REPORTS, 2018, 40 (03) : 1650 - 1656
  • [28] Synthesis, SAR and in vivo activity of CEP 5214, a novel and potent VEGFR2 kinase inhibitor.
    Gingrich, DE
    Albom, MS
    Yang, SX
    Angeles, TS
    Robinson, CS
    Hunter, K
    Chang, H
    Ruggeri, BA
    Hudkins, RL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U22 - U22
  • [29] Impact of aryloxy-linked quinazolines: A novel series of selective VEGFR-2 receptor tyrosine kinase inhibitors
    Garofalo, Antonio
    Goossens, Laurence
    Six, Perrine
    Lemoine, Amelie
    Ravez, Severine
    Farce, Amaury
    Depreux, Patrick
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (07) : 2106 - 2112
  • [30] Discovery of a Novel Series of Potent and Orally Bioavailable Phosphoinositide 3-Kinase γ Inhibitors
    Leahy, James W.
    Buhr, Chris A.
    Johnson, Henry W. B.
    Kim, Byung Gyu
    Baik, TaeGon
    Cannoy, Jonah
    Forsyth, Timothy P.
    Jeong, Joon Won
    Lee, Matthew S.
    Ma, Sunghoon
    Noson, Kevin
    Wang, Longcheng
    Williams, Matthew
    Nuss, John M.
    Brooks, Eric
    Foster, Paul
    Goon, Leanne
    Heald, Nathan
    Holst, Charles
    Jaeger, Christopher
    Lam, Scott
    Lougheed, Julie
    Lam Nguyen
    Plonowski, Arthur
    Song, Joanne
    Stout, Thomas
    Wu, Xiang
    Yakes, Michael F.
    Yu, Peiwen
    Zhang, Wentao
    Lamb, Peter
    Raeber, Olivia
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (11) : 5467 - 5482